Carneiro de Moura Miguel, Marinho Rui
Clínica Universitária de Gastrenterologia, Faculdade de Medicina de Lisboa e Hospital de Santa Maria, Lisboa, Portugal.
Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:11-8. doi: 10.1016/s0213-005x(08)76515-7.
Hepatitis B virus (HBV) infection is a serious public health problem worldwide. In the last few decades, major advances have been achieved that have contributed to greater understanding of the natural history and clinical manifestations of this infection. The fluctuation between viral replication and the host's immune response has implications in the pathogenesis and progression of the hepatic lesion. In immunocompetent adults, most HBV infections resolve spontaneously in contrast with progression to chronic infection in most infants. Patients with chronic hepatitis due to HBV or chronic hepatitis B can present at four phases: 1) the immune tolerance phase, 2) HBeAg-positive chronic hepatitis B, 3) inactive HBsAg carrier state, and 4) HBeAg-negative chronic hepatitis. HBeAg-positive or -negative chronic hepatitis can progress to cirrhosis, liver failure and hepatocellular carcinoma. Progression to these complications is more frequent in HBeAg-negative forms, associated with mutations that affect the pre-core region and maintain active viral replication. Risk factors are HBV-DNA positive serum levels, an increase in serum transaminase levels and some genotypes. These factors highlight the need to evaluate and monitor all HBV carriers to identify those who could benefit from early antiviral treatment, thus avoiding progression to more advanced forms of liver disease. These measures could improve prevention and treatment of hepatitis B.
乙型肝炎病毒(HBV)感染是一个全球性的严重公共卫生问题。在过去几十年中,取得了重大进展,有助于更深入地了解这种感染的自然史和临床表现。病毒复制与宿主免疫反应之间的波动对肝脏病变的发病机制和进展具有重要意义。在免疫功能正常的成年人中,大多数HBV感染可自发缓解,而大多数婴儿则会发展为慢性感染。慢性乙型肝炎病毒感染或慢性乙型肝炎患者可表现为四个阶段:1)免疫耐受期,2)HBeAg阳性慢性乙型肝炎,3)非活动性HBsAg携带状态,4)HBeAg阴性慢性肝炎。HBeAg阳性或阴性慢性肝炎可进展为肝硬化、肝衰竭和肝细胞癌。在HBeAg阴性形式中,进展为这些并发症的情况更为常见,这与影响前核心区并维持病毒活跃复制的突变有关。危险因素包括血清HBV-DNA阳性水平、血清转氨酶水平升高和某些基因型。这些因素凸显了对所有HBV携带者进行评估和监测的必要性,以识别那些可从早期抗病毒治疗中获益的患者,从而避免发展为更晚期的肝病形式。这些措施可改善乙型肝炎的预防和治疗。